REVELATION BIOSCIENCES, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Revelation Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q4 2024.
  • Revelation Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 172K shares, a 1104% increase year-over-year.
  • Revelation Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 172K shares, a 1104% increase from 2023.
  • Revelation Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 14.2K shares, a 80.4% decline from 2022.
  • Revelation Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 72.6K shares, a 74.3% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 172K +157K +1104% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 2.68M +2.42M +913% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 1.64M +1.39M +558% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-09-23
Q1 2024 1.09M +955K +705% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-09-23
Q4 2023 14.2K -58.3K -80.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 265K -347K -56.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 248K -193K -43.7% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-09-23
Q1 2023 135K -281K -67.5% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-09-23
Q4 2022 72.6K Oct 1, 2022 Dec 31, 2022 10-K/A 2024-09-23
Q3 2022 612K -5.68M -90.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 441K -5.85M -93% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 416K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q3 2021 6.29M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 6.29M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.